BSEBoard Meeting3d ago · 11 Nov 2026, 05:45 pm

Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026 and other allied matters.

Fischer Medical Ventures Ltd · 524743

✦ AI SummaryResults

Fischer Medical Ventures Ltd has scheduled a board meeting on 14th November 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fischer Medical Ventures Ltd - 524743 - Board Meeting Intimation for Approval Of Q2 Financial Results And Other Allied Matters.

Attachments (1)

📄

3b413df4-7f80-4848-901b-98bc9fb8ce18.pdf

pdf

Download →
View document text
FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 November 11, 2026 BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, 5th floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001. Mumbai - 400 051. BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir/ Madam, Sub: Intimation about the Board Meeting to be held on 14th November 2026 Ref: Regulation 29 of SEBI (LODR) Regulations 2015 as amended Pursuant to Regulation 29 of the Securities and exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, the 14th November 2026, through video conferencing, inter alia, i) to consider and take on record the unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30h September 2026, ii) to transact any other matter as may be specified in the agenda. As informed earlier vide our letter dated 25th September 2026, the trading window for dealing in the equity shares of the Company is already closed for all designated persons, their immediate relatives, other connected persons and shall remain closed until 48 hours after the declaration of the financial results of the Company for the quarter and half year ended 30th September 2026. This is for your information and records. Thanking You, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY & COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006